Desensitizing Distressing Recollections in Cancer Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-04-11

Study Completion Date

2017-09-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The major goal of this study is to determine whether Neuro-Emotional Technique is a viable treatment option for decreasing distress in cancer patients. The potential advantages of NET are: 1) it is designed specifically to address distressing stimuli and unresolved emotional memories; 2) it is a brief, time-limited intervention; and 3) its multi-modal design may appeal to and benefit a broader range of patients than a single mode intervention

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners

NCT03652298

Colorectal Cancer Bladder Cancer Prostate Cancer +2 more

TERMINATED PHASE2

Treatment Efficacy of Mindfulness-based Cognitive Therapy for Distress in Advanced Cancer Patients

NCT05768256

Cancer Pain Cancer Distress, Emotional +3 more

UNKNOWN NA

Narrative Exposure Therapy to Reduce Symptoms of Traumatic Stress in Cancer Survivors

NCT05272553

Traumatic Stress Disorder Cancer

UNKNOWN NA

The Modulatory Role of Internet MBCT on Extracellular Vesicles and Distress in Cancer Patients - Study Protocol

NCT04727593

Cancer

UNKNOWN NA

Mindfulness-based Virtual Reality Intervention

NCT05602051

Hematologic Neoplasms

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Subjects will receive NET intervention treatment immediately

Group Type EXPERIMENTAL

NET Intervention

Intervention Type BEHAVIORAL

Neuro-emotional Technique

Control

Subjects will receive NET intervention treatment and serve as a wait-list control

Group Type ACTIVE_COMPARATOR

NET Intervention

Intervention Type BEHAVIORAL

Neuro-emotional Technique

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NET Intervention

Neuro-emotional Technique

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years of age
* Distressing cancer-related recollection that has persisted for at least six months
* Distressing cancer-related recollection that causes physiological reactivity (i.e., increased heart rate and/or increased skin conductance level - SCL), as described in section 4.2.3.
* Received a cancer diagnosis at least 6 months prior to being contacted for participation in this study

Exclusion Criteria

* Any current Major Mental Disorder, as assessed by Structured Clinical Interview for DSM IV Axis I Disorders (SCID - Clinical Version, First et al, 1997)
* History of Post-traumatic Stress Disorder
* Current active mood primary disorder prior to the cancer diagnosis (as per PI or designate)
* History or current diagnosis of substance or alcohol abuse or dependence (as per PI or designate)
* Use of psychotropic medications within the past month or current use of medications that would interfere with autonomic nervous system measures (benzodiazepines, barbiturates, major tranquilizers).
* Use of some psychotropic medications are allowed such as SSRIs and certain sleep aids, but dosages must be stable from six weeks prior to enrollment and throughout study period
* Any psychological or musculoskeletal problems that would interfere with psychophysiological assessments and treatment
* Currently receiving chemotherapy or radiation
* Are in the terminal stages of illness

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No